Ingredients

Implications of the Pending Pfizer-Wyeth Mega Merger

February 04, 2009

PTSM: Pharmaceutical Technology Sourcing and Management

The pending merger of Pfizer and Wyeth provides Pfizer with greater strategic diversification, particularly in biologics, but only minimally addresses its generics exposure in the near term.

Inside IPEC: Regulation for Excipients is Brewing Across the Atlantic

February 02, 2009

Without any GMP guidelines for excipients in Europe, change can't come soon enough for some industry groups.

Pharma Capsules

February 02, 2009

Brief pharmaceutical news items for February 2009.

Going Green in Pharmaceuticals

February 02, 2009

The pharmaceutical majors forward projects in biocatalysis, solvent replacement, and other approaches in green chemistry.

Pharma Forecast

February 02, 2009

A recent reader poll focused on predictions for the industry's future.

Whither FDA?

February 02, 2009

FDA's role should not be overlooked as it has been in years past.

Pharmaceutical Technology Europe

Fast dissolving disintegrating tablets with isomalt

February 01, 2009

During the past years, there has been increasing demand for fast dissolving disintegrating tablets (FDDTs), such as orally disintegrating tablets (ODTs) and sublinguals.

Company and People Notes: FDA Issues Final Guidance on Genetically Engineered Animals; Bob Myers to Retire from PDA; More...

January 29, 2009

ePT--the Electronic Newsletter of Pharmaceutical Technology

Also, UCB will divest certain business in emerging markets to GSK; the KineMatik Group named Michael G. Jarjour president and CEO; more...

Pfizer Buys Wyeth and Cuts Jobs

January 29, 2009

ePT--the Electronic Newsletter of Pharmaceutical Technology

Pfizer will purchase Wyeth (Madison, NJ) under a definitive merger agreement approved by both companies' boards of directors.

Company and People Notes: Teva and Lonza to Form Joint Venture; USP Elects Duane M. Kirking Chairman; More...

January 22, 2009

ePT--the Electronic Newsletter of Pharmaceutical Technology

Also, Elan explores strategic alternatives; NanoGuardian appoints John D. Glover to lead its Security Advisory Board; more...